Natura &Co has announced its decision to delist from the New York Stock Exchange.

The decision to delist aligns with Natura &Co’s long-term strategic objectives of simplifying operations.

The beauty company will maintain its primary listing of common shares on the B3 stock exchange in São Paulo. Natura &Co said that the majority of its trading activity is concentrated on the B3 stock exchange, making the maintenance of the secondary listing on the NYSE less compelling.

The company expects the NYSE to suspend its trading on or around February 9. Natura &Co has clarified that it has no plans to arrange for the listing, quotation, and/or registration of the ADRs on another securities exchange or quotation medium.

“The planned delisting of Natura &Co from the New York Stock Exchange is consistent with our long-term strategy for the business,” said Fabio Barbosa, chief executive officer of Natura &Co.

“This move underscores our continued focus on simplifying our operations to reduce complexity. We thank Natura &Co investors who held ADRs and look forward to welcoming many of them as shareholders on the B3 market. Upholding our dedication to transparency, we will maintain our high disclosure standards through our listing in Brazil.”

Most recently, in November, Natura &Co sold the Body Shop to Aurelius at a loss, after a not-too-successful six years under its ownership. In 2023, it equally divested luxury beauty brand Aesop to L’Oréal.